MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Low dose trihexyphenidyl use causes cognitive dysfunction in Parkinson’s disease patients.

    L. Popil, M. Gavriliuc, A. Andrusca, O. Gavriliuc (Chisinau, Republic of Moldova)

    Objective: Evaluate cognitive performance in Parkinson's disease patients receiving a low dose of trihexyphenidyl (THP). Background: Before L-Dopa's discovery, anticholinergic drugs were among the first…
  • MDS Virtual Congress 2021

    Prognostic Modeling of Parkinson’s Disease Progression Using Early Longitudinal Patterns of Change

    X. Ren, J. Lin, G. Stebbins, C. Goetz, S. Luo (Foster City, CA, USA)

    Objective: To develop a prognostic model using multiple longitudinal measures to predict temporal clinical progression in early PD. Background: Predicting time to Parkinson’s disease (PD)…
  • MDS Virtual Congress 2021

    Falls in Parkinson’s Disease: The Impact of Cognitive Performance

    F. Rolim, A. Gomes, V. Santos, D. Torres, F. Carvalho (Fortaleza, Brazil)

    Objective: This study aimed to assess the incidence of falls in a population of PD patients and their clinical performance on cognitive assessment scales. Background:…
  • MDS Virtual Congress 2021

    The Functional Impact of REM Sleep Behavior Disorder in Parkinson’s Disease with Mild Cognitive Impairment

    R. Schade, E. Bayram (La Jolla, USA)

    Objective: This study examines whether severity and the functional impact of cognitive decline in Parkinson’s disease mild cognitive impairment (PD MCI) participants differ between those…
  • MDS Virtual Congress 2021

    Facial emotion recognition and social behavioral problems in de novo parkinson’s disease patients

    A. Slomp, S. Vander Zee, J. Boertien, M. Gerritsen, T. van Laar, J. Spikman (Groningen, Netherlands)

    Objective: To examine facial emotion recognition (FER) as crucial component of social cognition and its relationship with social-behavioral problems in de novo drug-naïve Parkinson’s disease…
  • MDS Virtual Congress 2021

    THE ABILITY OF PATIENTS WITH PARKINSON’S DISEASE TO RECOGNIZE MASKED FACES DURING COVID-19 PANDEMIC

    S. Tezcan Aydemir, M. Kuzu Kumcu, N. Durmaz çelik, B. Bakirarar, S. özkan, M. Akbostancı (Ankara, Turkey)

    Objective: This study aims to evaluate the effect of using masks on face recognition ability in Patients with Parkinson’s disease (PwP). Background: Patients with Parkinson’s…
  • MDS Virtual Congress 2021

    Effects of dopaminergic medication on reinforcement learning in Parkinson’s disease depend on depressive symptoms

    J. Tichelaar, C. Sayali, R. Helmich, R. Cools (Nijmegen, Netherlands)

    Objective: To investigate the effect of depression and dopaminergic medication on reinforcement learning (RL) in Parkinson’s disease. Background: Dopaminergic medication in PD is known to…
  • MDS Virtual Congress 2021

    Statistical methods for dealing with missing data in longitudinal studies with application to Parkinson’s disease cognition research

    P. Zhang, S. Xie (Philadelphia, USA)

    Objective: To assess the performance of standard techniques for handling missing data in longitudinal studies under a variety of missing data scenarios. We demonstrate our…
  • MDS Virtual Congress 2021

    The study of genetic factors in motor levodopa-induced complications development in Russian patients with Parkinson’s disease

    G. Akhmadeeva, I. Khidiyatova, I. Gilyazova, G. Tayupova, S. Umutbaev, A. Baitimerov, R. Magzhanov (Ufa, Russian Federation)

    Objective: The aim of our study is to search for genetic risk factors for the development of motor side effects of dopaminergic therapy, such as…
  • MDS Virtual Congress 2021

    EIF4G1 gene variants in a family affected by Parkinson´s disease

    C. Borrue (San Sebastián Reyes, Spain)

    Objective: Describe a novel mutation on a family affected by  Parkinson´s disease. Background: 46 years old woman. She came  to hospital complaining about  tremor and…
  • « Previous Page
  • 1
  • …
  • 763
  • 764
  • 765
  • 766
  • 767
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley